RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Glucagon-like peptide-1 receptor agonist liraglutide therapy for psoriasis patients with type 2 diabetes: a randomized-controlled trial

Glucagon-like peptide-1 receptor agonist liraglutide therapy for psoriasis patients with type 2 diabetes: a randomized-controlled trial

Add to Collection
RCTs L Lin, X Xu, Y Yu, H Ye, X He, S Chen… - Journal of …, 2022 - Taylor & Francis

Chapter : Section2, Section9
Journal Year : 2022
Cited by : 15

… risk factors (Citation3,Citation4). Glucagon-like peptide-1 receptor (GLP-1R) agonist liraglutide is a common hypoglycemic … safety of liraglutide in psoriasis patients with type 2 diabetes. …..... Read More

Keywords : ['glucagonlike receptor agonist liraglutide therapy', 'type diabetes', 'randomizedcontrolled trial', 'psoriasis patient']
PubMed Link : https://www.tandfonline.com/doi/abs/10.1080/09546634.2020.1826392
Google Scholar Link : https://scholar.google.com/scholar?cites=6529164688018873901&as_sdt=5,44&sciodt=0,44&hl=en&num=20